Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling

被引:137
|
作者
Paudel, Yam Nath [1 ]
Angelopoulou, Efthalia [2 ]
Piperi, Christina [2 ]
Balasubramaniam, Vinod R. M. T. [1 ]
Othman, Iekhsan [1 ]
Shaikh, Mohd Farooq [1 ]
机构
[1] Monash Univ Malaysia, Jeffrey Cheah Sch Med & Hlth Sci, Neuropharmacol Res Lab, Jalan Lagoon Selatan, Bandar Sunway, Selangor, Malaysia
[2] Natl & Kapodistrian Univ Athens, Med Sch, Dept Biol Chem, Athens, Greece
关键词
Inflammation; HMGB1; TLR4; LPS; Pro-inflammatory; DAMP; ACUTE LUNG INJURY; PATTERN-RECOGNITION RECEPTORS; END-PRODUCTS; THERAPEUTIC TARGET; CYTOKINE ACTIVITY; INHIBITING HMGB1; RAT MODEL; PROINFLAMMATORY ACTIVITY; MONOCLONAL-ANTIBODY; RECOMBINANT HMGB1;
D O I
10.1016/j.ejphar.2019.172487
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
High mobility group box 1 (HMGB1) is a ubiquitous protein, released passively by necrotic tissues or secreted actively by stressed cells. Extracellular HMGB1 is a typical damage-associated molecular pattern (DAMP) molecule which generates different redox types through binding with several receptors and signalling molecules, aggravating a range of cellular responses, including inflammation. HMGB1 is reported to participate in the pathogenesis of inflammatory diseases, through the interaction with pivotal transmembrane receptors, including the receptor for advanced glycation end products (RAGE) and toll-like receptor-4 (TLR-4). This review aims to highlight the role of HMGB1 in the innate inflammatory response describing its interaction with several cofactors and receptors that coordinate its downstream effects. Novel and underexplored HMGB1 binding molecules that have been actively involved in HMGB1-mediated inflammatory diseases/conditions with therapeutic potential are further discussed.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] A ROLE FOR TOLL-LIKE RECEPTOR 4 ACTIVATION BY THE HIGH MOBILITY GROUP BOX 1 (HMGB1) PROTEIN IN ICTOGENESIS
    Maroso, Mattia
    Balosso, S.
    Ravizza, T.
    Vanzulli, I.
    Aronica, E.
    Molteni, M.
    Rossetti, C.
    Liu, J.
    Bianchi, M. E.
    Vezzani, A.
    EPILEPSIA, 2009, 50 : 320 - 320
  • [22] A ROLE FOR TOLL-LIKE RECEPTOR 4 ACTIVATION BY THE HIGH MOBILITY GROUP BOX 1 (HMGB1) PROTEIN IN ICTOGENESIS
    Maroso, Mattia
    Balosso, S.
    Ravizza, T.
    Vanzulli, I.
    Aronica, E.
    Molteni, M.
    Rossetti, C.
    Liu, J.
    Bianchi, M. E.
    Vezzani, A.
    EPILEPSIA, 2009, 50 : 334 - 334
  • [23] Autoantibodies Against High Mobility Group Box 1 (HMGB1) in Patients with SLE
    Schaper, Fleur
    Horst, Gerda
    Henegouwen, Daan van Beijeren Bergenen
    Bijzet, Johan
    de Leeuw, Karina
    Stel, Alja
    Limburg, Pieter C.
    Heeringa, Peter
    Westra, Johanna
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S718 - S718
  • [24] High-mobility group box 1 (HMGB1) protein: Friend and foe
    Ulloa, Luis
    Messmer, Davorka
    CYTOKINE & GROWTH FACTOR REVIEWS, 2006, 17 (03) : 189 - 201
  • [25] High Mobility Group Box 1 (HMGB1) Levels in the Placenta and in Serum in Preeclampsia
    Wang, Bo
    Koga, Kaori
    Osuga, Yutaka
    Hirata, Tetsuya
    Saito, Ako
    Yoshino, Osamu
    Hirota, Yasushi
    Harada, Miyuki
    Takemura, Yuri
    Fujii, Tomoyuki
    Taketani, Yuji
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2011, 66 (02) : 143 - 148
  • [26] High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies
    Yuan, Shunling
    Liu, Zhaoping
    Xu, Zhenru
    Liu, Jing
    Zhang, Ji
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [27] High mobility group box 1 (HMGB1) induces tolerance to lipopolysaccharide(LPS).
    Aneja, Raiesh
    Sjodin, Hanna
    Robert, Stephen M.
    Fink, Mitchell P.
    Tsung, Allan
    Billiar, Timothy R.
    CRITICAL CARE MEDICINE, 2006, 34 (12) : A15 - A15
  • [28] High-mobility group box 1 (HMGB1) crosses the BBB bidirectionally
    Banks, William A.
    Hansen, Kim M.
    Erickson, Michelle A.
    Crews, Fulton T.
    BRAIN BEHAVIOR AND IMMUNITY, 2023, 111 : 386 - 394
  • [29] High Mobility Group Box-1 (HMGB1): A Potential Target in Therapeutics
    Vijayakumar, Eyaldeva C.
    Bhatt, Lokesh Kumar
    Prabhavalkar, Kedar S.
    CURRENT DRUG TARGETS, 2019, 20 (14) : 1474 - 1485
  • [30] High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies
    Shunling Yuan
    Zhaoping Liu
    Zhenru Xu
    Jing Liu
    Ji Zhang
    Journal of Hematology & Oncology, 13